178 related articles for article (PubMed ID: 35705114)
21. Targeting Myc in pediatric malignancies of the central and peripheral nervous system.
Grotzer MA; Castelletti D; Fiaschetti G; Shalaby T; Arcaro A
Curr Cancer Drug Targets; 2009 Mar; 9(2):176-88. PubMed ID: 19275758
[TBL] [Abstract][Full Text] [Related]
22. A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries.
Satgé D; Stiller CA; Rutkowski S; von Bueren AO; Lacour B; Sommelet D; Nishi M; Massimino M; Garré ML; Moreno F; Hasle H; Jakab Z; Greenberg M; von der Weid N; Kuehni C; Zurriaga O; Vicente ML; Peris-Bonet R; Benesch M; Vekemans M; Sullivan SG; Rickert C
J Neurooncol; 2013 Mar; 112(1):107-14. PubMed ID: 23307327
[TBL] [Abstract][Full Text] [Related]
23. Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB).
Bailey AW; Suri A; Chou PM; Pundy T; Gadd S; Raimondi SL; Tomita T; Sredni ST
Bioengineering (Basel); 2018 Nov; 5(4):. PubMed ID: 30400339
[TBL] [Abstract][Full Text] [Related]
24. Relapse patterns in pediatric embryonal central nervous system tumors.
Perreault S; Lober RM; Carret AS; Zhang G; Hershon L; Décarie JC; Yeom K; Vogel H; Fisher PG; Partap S
J Neurooncol; 2013 Nov; 115(2):209-15. PubMed ID: 23921420
[TBL] [Abstract][Full Text] [Related]
25. Nervous system: Embryonal tumors: Neuroblastoma.
Pudela C; Balyasny S; Applebaum MA
Atlas Genet Cytogenet Oncol Haematol; 2020 Jul; 24(7):284-290. PubMed ID: 32296467
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic Opportunities in Neuroblastoma Using Nanotechnology.
Rodríguez-Nogales C; Noguera R; Couvreur P; Blanco-Prieto MJ
J Pharmacol Exp Ther; 2019 Sep; 370(3):625-635. PubMed ID: 30635473
[TBL] [Abstract][Full Text] [Related]
27. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
Plant-Fox AS; O'Halloran K; Goldman S
Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
[TBL] [Abstract][Full Text] [Related]
28. [Epidemiology and pathology of brain tumors in childhood].
Giordana MT
Minerva Med; 1984 Jun; 75(24):1401-6. PubMed ID: 6330617
[TBL] [Abstract][Full Text] [Related]
29. Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors.
Heideman RL; Kovnar EH; Kellie SJ; Douglass EC; Gajjar AJ; Walter AW; Langston JA; Jenkins JJ; Li Y; Greenwald C
J Clin Oncol; 1995 Sep; 13(9):2247-54. PubMed ID: 7666082
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of Outcomes by Treatment Regimen and Histology in Central Nervous System Primary Embryonal Tumors.
Bhimani AD; Ryoo JS; Reddy AK; Denyer S; McGuire LS; Alonso M; Mehta AI
World Neurosurg; 2020 Sep; 141():e289-e306. PubMed ID: 32434022
[TBL] [Abstract][Full Text] [Related]
31. Intracranial Tumors in the First Year of Life.
Salomão JFM; Protzenko T
Adv Tech Stand Neurosurg; 2023; 46():23-52. PubMed ID: 37318568
[TBL] [Abstract][Full Text] [Related]
32. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].
Kortmann RD; Kühl J; Timmermann B; Calaminus G; Dieckmann K; Wurm R; Sörensen N; Urban C; Göbel U; Bamberg M
Strahlenther Onkol; 2001 Sep; 177(9):447-61. PubMed ID: 11591018
[TBL] [Abstract][Full Text] [Related]
33. LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT).
Rao S; Rajeswarie RT; Chickabasaviah Yasha T; Nandeesh BN; Arivazhagan A; Santosh V
Childs Nerv Syst; 2017 Nov; 33(11):1953-1959. PubMed ID: 28744687
[TBL] [Abstract][Full Text] [Related]
34. Significance and therapeutic value of miRNAs in embryonal neural tumors.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Molecules; 2014 May; 19(5):5821-62. PubMed ID: 24806581
[TBL] [Abstract][Full Text] [Related]
35. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
Gill P; Litzow M; Buckner J; Arndt C; Moynihan T; Christianson T; Ansell S; Galanis E
Cancer; 2008 Apr; 112(8):1805-11. PubMed ID: 18300237
[TBL] [Abstract][Full Text] [Related]
36. MYC as Therapeutic Target for Embryonal Tumors: Potential and Challenges.
Shalaby T; Grotzer MA
Curr Cancer Drug Targets; 2016; 16(1):2-21. PubMed ID: 26373717
[TBL] [Abstract][Full Text] [Related]
37. What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right.
Sun D; Zhou S; Gao W
ACS Nano; 2020 Oct; 14(10):12281-12290. PubMed ID: 33021091
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of SUN2, a novel tumor suppressor, mediates miR-221/222-induced malignancy in central nervous system embryonal tumors.
Hsieh TH; Chien CL; Lee YH; Lin CI; Hsieh JY; Chao ME; Liu DJ; Chu SS; Chen W; Lin SC; Ho DM; Liu RS; Lin CH; Wong TT; Wang HW
Carcinogenesis; 2014 Oct; 35(10):2164-74. PubMed ID: 24832085
[TBL] [Abstract][Full Text] [Related]
39. Insights into the Chemical Biology of Childhood Embryonal Solid Tumors by NMR-Based Metabolomics.
Quintero Escobar M; Maschietto M; Krepischi ACV; Avramovic N; Tasic L
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31817982
[TBL] [Abstract][Full Text] [Related]
40. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
Cole BL; Pierson CR
Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
